Amgen says no concerns around weight loss drug’s bone density data after stock falls
Read more at CNBC
-
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
Business - MarketWatch - November 4 -
Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms
Business - MarketWatch - October 24 -
RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.
Business - MarketWatch - 4 days ago -
Nurse’s death linked to approved weight-loss drug
Top stories - BBC News - November 8 -
Lilly's weight loss drug shortage deemed over, but hurdles remain
Top stories - CBS News - October 23 -
Weight loss drug industry injects wealth into Novo Nordisk home country
Top stories - CBS News - November 3 -
Counterfeit weight loss drugs sold online as demand for cheaper options grows
Top stories - CBS News - November 8
More from CNBC
-
Nvidia shares slump 3% in premarket as quarterly revenue growth slows
Business - CNBC - 1 hour ago -
Eli Manning, Derek Jeter, Jimmy Fallon join TGL New York Golf Club investor group
Business - CNBC - 29 minutes ago -
Adani Group slams 'baseless' New York fraud and bribery charges
Business - CNBC - 1 hour ago -
DOJ pushes for Google to break off Chrome browser after antitrust case
Business - CNBC - 6 hours ago -
Williams-Sonoma CEO explains pricing strategy after earnings beat
Business - CNBC - 11 hours ago